EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC0

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

Irene Orlow iD, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano, James S Wilmott, Anne E Cust, Richard A Scolyer iD, Graham J Mann, Tim K Lee, Hazel Burke, Valerie Jakrot und 41 weitere

PLOS ONE · 03.04.2023 · 18 (4) · e0269324

DOI: 10.1371/journal.pone.0269324 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS ONE, online erschienen am 03.04.2023. Verfasst von Irene Orlow und 52 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America. Hauptthemen laut MEDLINE: MicroRNAs, Melanoma, Nucleic Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We are conducting a multicenter study to identify classifiers predictive of disease-specific survival in patients with primary melanomas. Here we delineate the unique aspects, challenges, and best practices for optimizing a study of generally small-sized pigmented tumor samples including primary melanomas of at least 1.05mm from AJTCC TNM stage IIA-IIID patients. We also evaluated tissue-derived predictors of extracted nucleic acids’ quality and success in downstream testing. This ongoing study will target 1,000 melanomas within the international InterMEL consortium.

Methods

Following a pre-established protocol, participating centers ship formalin-fixed paraffin embedded (FFPE) tissue sections to Memorial Sloan Kettering Cancer Center for the centralized handling, dermatopathology review and histology-guided coextraction of RNA and DNA. Samples are distributed for evaluation of somatic mutations using next gen sequencing (NGS) with the MSK-IMPACT TM assay, methylation-profiling (Infinium MethylationEPIC arrays), and miRNA expression (Nanostring nCounter Human v3 miRNA Expression Assay).

Results

Sufficient material was obtained for screening of miRNA expression in 683/685 (99%) eligible melanomas, methylation in 467 (68%), and somatic mutations in 560 (82%). In 446/685 (65%) cases, aliquots of RNA/DNA were sufficient for testing with all three platforms. Among samples evaluated by the time of this analysis, the mean NGS coverage was 249x, 59 (18.6%) samples had coverage below 100x, and 41/414 (10%) failed methylation QC due to low intensity probes or insufficient Meta-Mixed Interquartile (BMIQ)- and single sample (ss)- Noob normalizations. Six of 683 RNAs (1%) failed Nanostring QC due to the low proportion of probes above the minimum threshold. Age of the FFPE tissue blocks (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMelanomaNucleic AcidsHumansTissue FixationDNAParaffin EmbeddingFormaldehyde

Substanzen

MicroRNAsNucleic AcidsDNAFormaldehyde

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Department of Dermatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America.
  • Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Irene Orlow, Richard A Scolyer, Peter M Ferguson, Pei-Fen Kuan

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS
  • Foundation for the National Institutes of Health
  • Australian Research Council
  • Faculty of Medicine and Health, University of Sydney
  • the Huntsman Foundation
  • Char and Chuck Fowler Family Foundation
  • Cleveland Foundation

Zitieren

APA

Orlow, I., Sadeghi, K. D., Edmiston, S. N., Kenney, J. M., Lezcano, C., Wilmott, J. S., Cust, A. E., Scolyer, R. A., Mann, G. J., Lee, T. K., Burke, H., Jakrot, V., Shang, P., Ferguson, P. M., Boyce, T. W., Ko, J. S., Ngo, P., Funchain, P., Rees, J. R., …, & InterMEL Consortium (2023). InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PLOS ONE, 18(4), e0269324. https://doi.org/10.1371/journal.pone.0269324

Vancouver

Orlow I, Sadeghi KD, Edmiston SN, Kenney JM, Lezcano C, Wilmott JS, et al. InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma. PLOS ONE. 2023;18(4):e0269324. doi:10.1371/journal.pone.0269324

BibTeX
@article{Orlow2023,
  author = {Orlow, Irene and Sadeghi, Keimya D and Edmiston, Sharon N and Kenney, Jessica M and Lezcano, Cecilia and Wilmott, James S and Cust, Anne E and Scolyer, Richard A and Mann, Graham J and Lee, Tim K and Burke, Hazel and Jakrot, Valerie and Shang, Ping and Ferguson, Peter M and Boyce, Tawny W and Ko, Jennifer S and Ngo, Peter and Funchain, Pauline and Rees, Judy R and O'Connell, Kelli and Hao, Honglin and Parrish, Eloise and Conway, Kathleen and Googe, Paul B and Ollila, David W and Moschos, Stergios J and Hernando, Eva and Hanniford, Douglas and Argibay, Diana and Amos, Christopher I and Lee, Jeffrey E and Osman, Iman and Luo, Li and Kuan, Pei-Fen and Aurora, Arshi and Gould Rothberg, Bonnie E and Bosenberg, Marcus W and Gerstenblith, Meg R and Thompson, Cheryl and Bogner, Paul N and Gorlov, Ivan P and Holmen, Sheri L and Brunsgaard, Elise K and Saenger, Yvonne M and Shen, Ronglai and Seshan, Venkatraman and Nagore, Eduardo and Ernstoff, Marc S and Busam, Klaus J and Begg, Colin B and Thomas, Nancy E and Berwick, Marianne and InterMEL Consortium, InterMEL Consortium},
  title = {InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {4},
  pages = {e0269324},
  doi = {10.1371/journal.pone.0269324}
}
Kostenlos starten →